Table 4.

Indication, use and assessment of aminoglycosides in patients with S. aureus IE (infective endocarditis) according to methicillin susceptibility

	IE due to MSSA (n = 17)	IE due to MRSA (n = 9)	p
Indication of aminoglycosides	15 (88.2)	9 (100)	= 0.28
Delivery of aminoglycosides	14 (82.3)	4 (44.4)	<  0.05
Use of aminoglycosides in patients with indication	12 (70.6)	4 (44.4)	= 0.18
Aminoglycosides conformity	12 (70.6)	4 (44.4)	= 0.18
Number of deaths	2 (11.8)	3 (33.3)	= 0.18

Data are presented as No (%)

MSSA methicillin-susceptible S. aureus

MRSA methicillin-resistant S. aureus